Literature DB >> 9269814

Effect of epidural anesthesia on colorectal anastomosis: a tonometric assessment.

C Sala1, E García-Granero, M J Molina, J V García, S Lledo.   

Abstract

PURPOSE: Epidural anesthesia is believed to benefit colorectal anastomotic blood flow because of the sympathetic blockade it produces. Our purpose is to measure with tonometry the effect of epidural anesthesia on colorectal anastomotic oxygenation. PATIENTS AND METHODS: Fifteen patients operated on for rectal cancer (radical anterior resection) were monitored postoperatively using tonometers placed in the stomach (celiac trunk), transverse colon (superior mesenteric artery), and the anastomotic area during the operation. An epidural catheter was placed at L1-2, and on the first postoperative day, 8 ml of bupivacaine (0.25 percent) was administered. The anesthetic effect extended up to T-4. Intramucosal pH (pHi) at the three locations was measured before, during, and after the epidural blockade.
RESULTS: Gastric and transverse colon pHi increased during the epidural blockade from 7.35 +/- 0.01 to 7.41 +/- 0.01 and from 7.34 +/- 0.02 to 7.40 +/- 0.02, respectively. The anastomotic pHi decreased from 7.3 +/- 0.02 to 7.24 +/- 0.03 under the epidural and increased up to 7.34 +/- 0.02 after withdrawal of the effect on the following day. All pHi variations were statistically significant (P < 0.05, paired Student's t-test and Wilcoxon's test), because it was the comparison between gastric and transverse colon pHi with the anastomotic pHi during the epidural (P < 0.05, one-way analysis of variance and Kruskal-Wallis tests). None of the patients developed anastomotic or other complications.
CONCLUSIONS: Epidural anesthesia with bupivacaine causes a significant decrease in the oxygenation-perfusion state of colorectal anastomosis in comparison with the increase in other areas of the digestive tract. Further studies need to be done to see if other epidural anesthetic-analgesic protocols also worsen colorectal anastomotic blood flow.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269814     DOI: 10.1007/bf02051205

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  The role of epidural anesthesia and analgesia in surgical practice.

Authors:  Robert J Moraca; David G Sheldon; Richard C Thirlby
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

2.  A nationwide analysis of the use and outcomes of epidural analgesia in open colorectal surgery.

Authors:  Wissam J Halabi; Mehraneh D Jafari; Vinh Q Nguyen; Joseph C Carmichael; Steven Mills; Michael J Stamos; Alessio Pigazzi
Journal:  J Gastrointest Surg       Date:  2013-04-18       Impact factor: 3.452

3.  Laser Doppler assessment of the influence of division at the root of the inferior mesenteric artery on anastomotic blood flow in rectosigmoid cancer surgery.

Authors:  Kazuhiro Seike; Keiji Koda; Norio Saito; Kenji Oda; Chihiro Kosugi; Kimio Shimizu; Masaru Miyazaki
Journal:  Int J Colorectal Dis       Date:  2006-11-03       Impact factor: 2.571

4.  Short-Term Outcomes of Epidural Analgesia in Minimally Invasive Esophagectomy for Esophageal Cancer: Nationwide Inpatient Data Study in Japan.

Authors:  Yuki Hirano; Hidehiro Kaneko; Takaaki Konishi; Hidetaka Itoh; Satoru Matsuda; Hirofumi Kawakubo; Kazuaki Uda; Hiroki Matsui; Kiyohide Fushimi; Hiroyuki Daiko; Osamu Itano; Hideo Yasunaga; Yuko Kitagawa
Journal:  Ann Surg Oncol       Date:  2022-08-12       Impact factor: 4.339

5.  Epidural analgesia for pancreatoduodenectomy: a critical appraisal.

Authors:  Wande B Pratt; Richard A Steinbrook; Shishir K Maithel; Tsafrir Vanounou; Mark P Callery; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2008-02-09       Impact factor: 3.452

6.  Ultrasonography guided rectus sheath catheters versus epidural analgesia for open colorectal cancer surgery in a single centre.

Authors:  A R Godden; M J Marshall; A S Grice; I R Daniels
Journal:  Ann R Coll Surg Engl       Date:  2013-11       Impact factor: 1.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.